Clinical trials
Terminated Psychotic Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre for Addiction and Mental Health | 3 |
| Boehringer Ingelheim | 1 |
| Centre de Recherche de l'Institut Universitaire en Santé Mentale de Québec | 1 |
| Mediti Pharma Inc. | 1 |
| Nova Scotia Health Authority | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| TheraGenetics Limited | 1 |
| University of British Columbia | 1 |
| University of Calgary | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Psychotic Disorders | 12 |
| Schizophrenia | 7 |
| Metabolic Syndrome | 2 |
| Alzheimer Disease | 1 |
| Anxiety Disorders | 1 |
| Dementia | 1 |
| Hypersensitivity | 1 |
| Mental Disorders | 1 |
| Psychomotor Agitation | 1 |
| Schizophrenia Spectrum and Other Psychotic Disorders | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.